Benzinga | Feb 2, 2021 06:17AM EST

Haemonetics Q3 Adj. EPS $0.81 Beats $0.65 Estimate, Sales $240.37M Beat $224.29M Estimate

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.81 per share which beat the analyst consensus estimate of $0.65 by 24.62 percent. This is a 13.83 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $240.37 million which beat the analyst consensus estimate of $224.29 million by 7.17 percent. This is a 7.18 percent decrease over sales of $258.97 million the same period last year.